Cargando…

The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists

In order to search for novel antipsychotics acting through the D(2) receptor, it is necessary to know the structure–activity relationships for dopamine D(2) receptor antagonists. In this context, we constructed the universal three-dimensional quantitative structure–activity relationship (3D- QSAR) m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zięba, Agata, Żuk, Justyna, Bartuzi, Damian, Matosiuk, Dariusz, Poso, Antti, Kaczor, Agnieszka A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770028/ https://www.ncbi.nlm.nih.gov/pubmed/31540025 http://dx.doi.org/10.3390/ijms20184555

Ejemplares similares

Preferential Coupling of Dopamine D(2S) and D(2L) Receptor Isoforms with G(i1) and G(i2) Proteins—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2020)

Comparative molecular field analysis and molecular dynamics studies of the dopamine D(2) receptor antagonists without a protonatable nitrogen atom
por: Kaczor, Agnieszka A., et al.
Publicado: (2018)

The Role of Lipids in Allosteric Modulation of Dopamine D(2) Receptor—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2022)

Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
por: Zięba, Agata, et al.
Publicado: (2021)

Allosteric modulation of dopamine D(2L) receptor in complex with G(i1) and G(i2) proteins: the effect of subtle structural and stereochemical ligand modifications
por: Żuk, Justyna, et al.
Publicado: (2022)

Development and Characterization of Novel Selective, Non-Basic Dopamine D(2) Receptor Antagonists for the Treatment of Schizophrenia
por: Stępnicki, Piotr, et al.
Publicado: (2023)

Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors
por: Bartuzi, Damian, et al.
Publicado: (2017)

Overcoming Depression with 5-HT(2A) Receptor Ligands
por: Zięba, Agata, et al.
Publicado: (2021)

Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors
por: Bartuzi, Damian, et al.
Publicado: (2017)

Novel Positive Allosteric Modulators of µ Opioid Receptor—Insight from In Silico and In Vivo Studies
por: Bartuzi, Damian, et al.
Publicado: (2020)

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery
por: Zięba, Agata, et al.
Publicado: (2023)

Allosteric Modulators of Dopamine D(2) Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
por: Kaczor, Agnieszka A., et al.
Publicado: (2022)

Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D(2) Receptor Ligand
por: Kondej, Magda, et al.
Publicado: (2018)

Thyroid Peroxidase Activity is Inhibited by Phenolic Compounds—Impact of Interaction
por: Habza-Kowalska, Ewa, et al.
Publicado: (2019)

Current Approaches and Tools Used in Drug Development against Parkinson’s Disease
por: Koszła, Oliwia, et al.
Publicado: (2021)

Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor
por: Kaczor, Agnieszka A., et al.
Publicado: (2014)

The dopamine D(2) receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics
por: Kaczor, Agnieszka A., et al.
Publicado: (2016)

Experimental and Computational Structural Studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted Indoles as Non-Competitive Antagonists of GluK1/GluK2 Receptors
por: Bartyzel, Agata, et al.
Publicado: (2022)

Studies of New Fused Benzazepine as Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics
por: Liu, Jing, et al.
Publicado: (2011)

Comparison of Different 2D and 3D-QSAR Methods on Activity Prediction of Histamine H3 Receptor Antagonists
por: Dastmalchi, Siavoush, et al.
Publicado: (2012)

Structure-based development of caged dopamine D(2)/D(3) receptor antagonists
por: Gienger, Marie, et al.
Publicado: (2020)

Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes
por: Bartuzi, Damian, et al.
Publicado: (2022)

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
por: Zhao, Manman, et al.
Publicado: (2017)

Distinct Dopamine D(2) Receptor Antagonists Differentially Impact D(2) Receptor Oligomerization
por: Wouters, Elise, et al.
Publicado: (2019)

Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D(2) and D(3) Receptors
por: Newton, Claire L., et al.
Publicado: (2016)

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
por: Maramai, Samuele, et al.
Publicado: (2016)

Dibenzazecine compounds with a novel dopamine/5HT(2A )receptor profile and 3D-QSAR analysis
por: Hamacher, Alexandra, et al.
Publicado: (2006)

Effects of dopamine D(4 )receptor antagonist on spontaneous alternation in rats
por: Moustgaard, Anette, et al.
Publicado: (2008)

Pharmacophore Modelling and 3D-QSAR Studies on N(3)-Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists
por: Kaur, Paramjit, et al.
Publicado: (2012)

Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response
por: Bhathena, A, et al.
Publicado: (2013)

Rethinking 3D-QSAR
por: Cramer, Richard D.
Publicado: (2010)

Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D(3) Receptor Antagonists
por: Chen, Jianyong, et al.
Publicado: (2014)

Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
por: Ferruz, Noelia, et al.
Publicado: (2018)

Discovery, Optimization, and Characterization of Novel D(2) Dopamine Receptor Selective Antagonists
por: Xiao, Jingbo, et al.
Publicado: (2014)

Effect of Dopamine D(2) Receptor Antagonists on [(18)F]-FEOBV Binding
por: Schildt, Anna, et al.
Publicado: (2020)

Dopamine D1 Receptor in Cancer
por: Sobczuk, Paweł, et al.
Publicado: (2020)

The Three Dimensional Quantitative Structure Activity Relationships (3D-QSAR) and Docking Studies of Curcumin Derivatives as Androgen Receptor Antagonists
por: Xu, Guanhong, et al.
Publicado: (2012)

Single exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methylphenidate effect
por: Claussen, Catherine M, et al.
Publicado: (2015)

A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
por: Marsango, Sara, et al.
Publicado: (2017)

Synthesis, Central Nervous System Activity and Structure-Activity Relationships of Novel 1-(1-Alkyl-4-aryl-4,5-dihydro-1H-imidazo)-3-substituted Urea Derivatives
por: Szacoń, Elżbieta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_volnqie8lql48vdaduu5tta9d6